Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

New System Reveals Whether School Wellness Policies 'Make The Grade'
In an effort to help families and school administrators fight the epidemic of obesity among children, a Yale-led team of researchers has developed a practical coding system to evaluate school wellness policies, which are required of all schools participating in the National School Lunch Program. This coding system was introduced in the July 2009 issue of the Journal of the American Dietetic Association.
generic viagra online
Dry Mouth Linked To Prescription And Over The Counter Drugs
Approximately ninety-one percent of dentists say patients complaining about dry mouth are taking multiple medications, according to a nationwide member survey conducted by the Academy of General Dentistry (AGD). Dry mouth, or xerostomia, is caused by a decrease in salivary function. It affects approximately one in four Americans, placing more than 25 percent of people at risk for tooth decay. During the Academy of General Dentistry"s (AGD) 57th Annual Meeting & Exhibits in Baltimore, July 8-12, Cindy Kleiman, RDH, BS, will present a course, "Understanding the Oral-Systemic Connection: From Intensive Care to Long-term Care," in which she presents new information about dry mouth.
News of the day
Acura And King Receive FDA Complete Response Letter Regarding Acurox(R)
Acura Pharmaceuticals, Inc. (Nasdaq: ACUR) and King Pharmaceuticals, Inc. (NYSE: KG) announced today that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter regarding the New Drug Application (NDA) for Acurox (oxycodone HC1, USP and niacin, USP) Tablets CII, an immediate release product intended for the relief of moderate-to-severe pain.
Health Insurance

Covidien Announces Health Canada Approval For Its Generic Myocardial Perfusion Imaging Kit

Covidien (NYSE: COV), a leading global provider of healthcare products, announced that Health Canada has approved the Company"s Abbreviated New Drug Submission (ANDS) for its Kit for the Preparation of Technetium Tc 99m Sestamibi Injection. Covidien"s generic product is fully substitutable for Cardiolite®, a myocardial perfusion imaging agent used for detecting coronary artery disease. With Health Canada approval of the ANDS, which was filed by the Company"s Canadian subsidiary, Covidien"s generic product is expected to be available for customers in Canada this summer. The Company"s generic product also is available in the U.S., the U.K., Denmark, Germany and Puerto Rico. "We are pleased to receive approval in Canada and to introduce this generic diagnostic option to meet patients" needs," said Timothy R. Wright, President, Pharmaceutical Products and Imaging Solutions, Covidien. Covidien"s Imaging Solutions business is a leading provider of radiopharmaceuticals used in nuclear medicine imaging procedures. It also supplies contrast media delivery systems, which combine contrast media and power injectors, for Computed Tomography (CT), X-ray and Magnetic Resonance Imaging (MRI) procedures. Covidien


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009